Literature DB >> 8499820

Hyponatraemic convulsion associated with desmopressin and imipramine treatment.

M Hamed1, H Mitchell, D J Clow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8499820      PMCID： PMC1677667          DOI： 10.1136/bmj.306.6886.1169

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Drug-induced dilutional hyponatremia.

Authors:  A M Moses; M Miller
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

2.  Syndrome of inappropriate antidiuretic hormone with imipramine.

Authors:  R A Mitsch; A K Lee
Journal:  Drug Intell Clin Pharm       Date:  1986-10
  2 in total
  8 in total

1.  Amitriptyline versus vasopressin in the treatment of nocturnal enuresis.

Authors:  W L Robson; J P Nørgaard
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 2.  Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

Authors:  W L Robson; J P Nørgaard; A K Leung
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

3.  Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis.

Authors:  D C Apakama; A Bleetman
Journal:  J Accid Emerg Med       Date:  1999-05

4.  Use caution in prescribing desmopressin for nocturnal enuresis.

Authors:  J Hourihane; A J Salisbury
Journal:  BMJ       Date:  1993-06-05

5.  Hyponatraemia following desmopressin.

Authors:  W L Robson; A K Leung
Journal:  BMJ       Date:  1993-07-03

Review 6.  Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.

Authors:  T Y Chan
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 7.  Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

Authors:  O Spigset; K Hedenmalm
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

8.  Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).

Authors:  Marcus J Drake; Luke Canham; Nikki Cotterill; Debbie Delgado; Jenny Homewood; Kirsty Inglis; Lyndsey Johnson; Mary C Kisanga; Denise Owen; Paul White; David Cottrell
Journal:  BMC Neurol       Date:  2018-08-06       Impact factor: 2.474
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.